Cargando…
MYC degradation via AURKB inhibition: a new brake in the path to T-ALL
Autores principales: | Zhang, Wu, Pear, Warren S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975048/ https://www.ncbi.nlm.nih.gov/pubmed/35402818 http://dx.doi.org/10.1097/BS9.0000000000000046 |
Ejemplares similares
-
Gemin6 promotes c‐Myc stabilisation and non‐small cell lung cancer progression via accelerating AURKB mRNA maturation
por: Lin, Jie, et al.
Publicado: (2022) -
MYC Oncogene Contributions to Release of Cell Cycle Brakes
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019) -
AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021) -
Haspin inhibition reveals functional differences of interchromatid axis–localized AURKB and AURKC
por: Quartuccio, Suzanne M., et al.
Publicado: (2017) -
AURKB promotes gastric cancer progression via activation of CCND1 expression
por: Nie, Min, et al.
Publicado: (2020)